# Vaccination With PD-L1 Peptide Against Multiple Myeloma

> **NCT03042793** · PHASE1 · COMPLETED · sponsor: **Lene Meldgaard Knudsen** · enrollment: 10 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** PD-L1 peptide vaccine

## Key facts

- **NCT ID:** NCT03042793
- **Lead sponsor:** Lene Meldgaard Knudsen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2020-05-14
- **Final completion:** 2020-05-14
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03042793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03042793, "Vaccination With PD-L1 Peptide Against Multiple Myeloma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03042793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*